Search Results

This device is intended for medical purpose that is worn on the examination between patient and examiner. In addition, these examination gloves were tested for use with the following chemotherapy drug concentrations per ASTN D6978-05(2019):

The following drugs had NO breakthrough detected up to 240 minutes:
Cisplatin, 1.0 mg/ml (1,000 ppm)
Cyclophosphamide (Cytoxan),20.0 mg/ml (20,000 ppm)
Dacarbazine, 10.0 mg/ml (10,000 ppm)
Doxorubicin HCI, 2.0 mg/ml (2,000 ppm)
Etoposide, 20.0 mg/ml (20,000 ppm)
Fluorouracil, 50.0 mg/ml (50,000 ppm)
Paclitaxel, 6.0 mg/ml (6,000 ppm)

Please note that the following drugs have low permeation times of less than 240 minutes: Carmustine (BCNU) 3.3 mg/ml (3,300 ppm), 34.4minutes ThioTepa10.0 mg/ml (10,000 ppm),88.5 minutes

WARNING: Do not use with Carmustine and Thiotepa

Disposable Medical Nitrile Examination Gloves -Tested for Use with Chemotherapy Drugs

This document describes the FDA's clearance of "Disposable Medical Nitrile Examination Gloves - Tested for Use with Chemotherapy Drugs" (K220491). This is a medical device, specifically a non-powdered patient examination glove, and the information provided details its intended use and testing against chemotherapy drugs.

This section does not contain information about an AI/ML device or its performance criteria, study design, or ground truth establishment. The document is a clearance letter for a physical medical device (gloves) and focuses on their chemical resistance properties.

Therefore, I cannot provide the requested information about acceptance criteria, study details, sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, or ground truth for an AI/ML device based on this input.

Ask a specific question about this device